RT @JAMA_current: The first randomized clinical trial of convalescent plasma in #COVID19, reported by Li et al in JAMA s
Tweet Content
The first randomized clinical trial of convalescent plasma in #COVID19, reported by Li et al in JAMA suggests that high titer antibody against #SARSCoV2 may have antiviral efficacy https://t.co/6YIib2GXGX
Links
A Randomized Trial of Convalescent Plasma for COVID-19—Potentially Hopeful Sign…
https://ja.ma/2XUf0U4
Show on Archive Page
On
Display in Search Results
On